Apogee Therapeutics Inc (APGE)

70.73 -0.83%

Apogee Therapeutics Inc (APGE) is currently trading at $70.73. This represents a loss of 0.83% from the previous session. With a market capitalization of $4.87B, APGE is a key component of the Health Care sector. Investors looking to trade APGE should compare margin rates and options platforms to optimize their portfolio management.

Broker Promotion
Claim Your $300 Cash Bonus → T&Cs Apply. Trade APGE commission-free.
Trading Platform Comparison
Moomoo
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Good for small traders
IBKR
  • Min Deposit: $0
  • Commissions: $0–$0.005/share
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Professional-level tools
Ameritrade
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Strong research tools
Webull
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Easy mobile app
AI Market Sentiment

As of today, Apogee Therapeutics Inc (APGE) shows a bearish trend. Analysts are watching the 73.71 level closely.

Fundamentals
Mkt Cap4.87B
P/E Ratio0.0000
Volume345,521
Others Watching (By Market Cap)
BMRN
Biomarin Pharma $61.48
-1.96% EXEL
Exelixis Inc $44.85
-0.64% RNA
Avidity Bioscie $72.80
+0.06% EHC
Encompass Healt $106.11
+1.21% BAX
Baxter Internat $20.69
+0.73%
60-Day Technical Chart
Advanced Charting

Need more indicators for APGE? Use the world's #1 platform.

Open APGE on TradingView →
Charting Platforms
TradingView

Advanced charts & indicators, web & mobile

StockCharts

Technical analysis charts with overlays & indicators

BarCharts

Market data, charts, and technical signals

Finviz

Visual stock charts & heatmaps

Yahoo Finance Charts

Basic interactive charts with indicators

Side-by-Side: Stocks Near $71
Metric APGE
-0.83% 		HOOD
+5.44% 		UBER
+1.95% 		FCX
+1.18%
Price $70.73 $77.32 $72.73 $68.71
Mkt Cap $4.87B $69.69B $149.91B $99.50B
- View → View → View →
Latest Headlines
Apogee Therapeutics, Inc. (APGE) Stock Analysis: A Promising Biotech with Nearly 50% Upside Potential DirectorsTalk Interviews • Feb 25, 2026 End of Apogee (APGE) Drug Collaboration Leads to Revised Analyst Expectations Yahoo Finance • Feb 19, 2026 $APGE stock is down 12% today. Here's what we see in our data. Quiver Quantitative • Jan 23, 2026 $300M Offering: Apogee Therapeutics Prices 6.95M Shares; Includes Pre-funded Warrants Exercisable Immediately Stock Titan • Oct 8, 2025 Here is Why Apogee Therapeutics (APGE) Appears Attractive Yahoo Finance • Feb 16, 2026
● Gemini Agentic AI Analyst Insight for APGE
Market Education
View All Articles →
External Research